The results showed that high-dose cisplatin alone did not affect the above proteins, while overexpression of LncRNA ADAMTS9 significantly increased the expression levels of NLRP3 and ASC in cisplatin treated CR-GC cells (Figure 7A–7D). The gene discussed is NLRP3; the disease is gastric cancer.